Shafaq Zia is a science journalist and a graduate student in the Graduate Program in Science Writing at the Massachusetts Institute of Technology. Previously, she was a reporting intern at STAT, covering the COVID-19 pandemic and the latest research in health technology.
Shafaq Zia
From this contributor
Spotted around the web: COVID-19 during pregnancy, sleep problems, eugenics
Here is a roundup of news and research for the week of 6 June.
Spotted around the web: COVID-19 during pregnancy, sleep problems, eugenics
New resource tracks genetic variations in Han Chinese populations
An online database called NyuWa catalogs genetic variations among nearly 3,000 individuals and provides a comprehensive reference genome for the Han people.
New resource tracks genetic variations in Han Chinese populations
Explore more from The Transmitter
‘Overdue’ debate unfurls over neuroimaging method
After a January paper questioned the validity of an approach called lesion network mapping, its users are pressure testing their results.
‘Overdue’ debate unfurls over neuroimaging method
After a January paper questioned the validity of an approach called lesion network mapping, its users are pressure testing their results.
Nearly 400 compounds affect behaviors tied to autism-linked genes in zebrafish
Estropipate, paclitaxel and levocarnitine altered behaviors tied to SCN2A and DYRK1A variants specifically, a new open-source platform revealed.
Nearly 400 compounds affect behaviors tied to autism-linked genes in zebrafish
Estropipate, paclitaxel and levocarnitine altered behaviors tied to SCN2A and DYRK1A variants specifically, a new open-source platform revealed.
What neuroscientists want from a new NINDS director
The search is underway for the next director of the U.S. National Institute of Neurological Disorders and Stroke, who will face a range of challenges, neuroscientists say, but will also have an “immense opportunity to do good things.”
What neuroscientists want from a new NINDS director
The search is underway for the next director of the U.S. National Institute of Neurological Disorders and Stroke, who will face a range of challenges, neuroscientists say, but will also have an “immense opportunity to do good things.”